Neonates born after elective repeat cesarean delivery are about twice as likely to be admitted to the NICU when compared to those born vaginally after a previous cesarean.
Neonates born after elective repeat cesarean delivery are about twice as likely to be admitted to the neonatal intensive care unit (NICU) (9.3% vs. 4.9%; P=.025) and about twice as likely to require oxygen supplementation for delivery room resuscitation (41.5% vs. 23.2%; P<.01) and after NICU admission (5.8% vs. 2.4%; P<.028), when compared to those born vaginally after a previous cesarean (VBAC), according to the results of a retrospective cohort study involving 672 women with one prior CD.
While neonates born by VBAC required the least delivery room resuscitation with oxygen, those born after failed VBAC required the most, underscoring the necessity of being able to successfully choose those women most likely to succeed at VBAC. The study reported that the factors that increased the likelihood of a failed VBAC include chorioamnionitis and induction of labor.
Not surprisingly, failed VBACs also accounted for the most expensive total birth experience, including delivery and NICU use, followed by elective repeat CD with labor, and elective repeat CD without labor. Successful VBACs were the least expensive.
Kamath BD, Todd JK, Glazner JE, et al. Neonatal outcomes after elective cesarean delivery. Obstet Gynecol. 2009;113:1231-1238.
Hormone therapy safety: Study finds potential benefits for senior women
April 24th 2024A recent large-scale study challenged age-related concerns, suggesting hormone therapy may offer safety and even benefits for menopausal women aged over 65 years, aligning with The Menopause Society's 2022 Position Statement.
Read More
Hyperoxygenation use not linked to neonatal outcomes
April 23rd 2024Recent research evaluated the impact of maternal hyperoxygenation on neonatal Apgar scores, revealing no significant enhancement in outcomes among women with pathologic fetal heart rate tracing and suggesting limited efficacy of hyperoxygenation therapy in this context.
Read More
Study finds antihypertensive treatment reduces uterine fibroids risk
April 23rd 2024A recent study revealed that patients with untreated or new-onset hypertension face elevated chances of uterine fibroid diagnosis, underscoring the potential of antihypertensive therapy in mitigating this risk among midlife individuals.
Read More